Kelactin 50 µg/ml oral solution
Kelactin 50 µg/ml oral solution
Authorised
- Cabergoline
Product identification
Medicine name:
Kelactin 50 µg/ml oral solution
Kelactin Vet. 50 mikrogram/ml oral opløsning
Active substance:
- Cabergoline
Target species:
-
Cat
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Cabergoline50.00microgram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral solution
Withdrawal period by route of administration:
-
Oral use
- Cat
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QG02CB03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Denmark
Available in:
-
Denmark
Package description:
- Kelactin 50 µg/ml or. sol. 24 ml (glass type II)
- Kelactin 50 µg/ml or. sol. 14 ml (glass type III)
- Kelactin 50 µg/ml or. sol. 7 ml (glass type III)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Veyx Pharma GmbH
Responsible authority:
- Danish Health And Medicines Authority
Authorisation number:
- 48957
Date of authorisation status change:
Reference member state:
-
Belgium
Procedure number:
- BE/V/0025/001
Concerned member states:
-
Cyprus
-
Czechia
-
Denmark
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Italy
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Slovakia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
Generic of:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: